Female Reproductive System Carcinoma — Trials

Female Reproductive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,481 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 458
Recruiting: 230
Ph III recruiting: 25
Growth YoY: +35.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (201)

clinicaltrialsPublishedShowing 151–158 of 158 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02435186	p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer	unknown	Phase 2	100	Shenzhen SiBiono GeneTech Co.,LtdINDUSTRY	1	May 6, 2015	clinicaltrials
NCT02368067	Improved Method of Detecting Cancer Metastases(SITs)	unknown	N/A	30	Southeastern Regional Medical CenterOTHER	1	Feb 20, 2015	clinicaltrials